Clinical trial Recruiting at 1 site Interventional Ages 0 Weeks to 12 Weeks

Mastisol to help casts stay on for infants with bilateral clubfoot

Official title: A Randomized Controlled Trial Comparing Outcomes and Complications Following Mastisol Application for Clubfoot Casting

Run by University of Wisconsin, Madison · NCT07154550 · Data updated 2026-11-12

This trial tests whether applying Mastisol adhesive before casting helps infants with bilateral clubfoot keep their casts on, shorten treatment, and reduce complications during casting and up to five years afterward.

More Club Foot trials

Quick facts

Study typeInterventional
Ages0 Weeks to 12 Weeks
SexAll
Enrollment100 (estimated)
SponsorUniversity of Wisconsin, Madison
Academic / other
Locations1 site (Madison, Wisconsin)
StatusRecruiting
StartedFebruary 11, 2026
Main results expectedNovember 2032
Study endsNovember 2032
Registry record updatedAugust 10, 2026
Trial IDNCT07154550 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants aged 0–12 weeks with bilateral clubfoot starting Ponseti casting whose parent or guardian can read and speak English and provide consent are ideal candidates.

Probably not a fit

Children with unilateral clubfoot, those who begin treatment after 12 weeks of age, or infants whose caregivers cannot provide informed consent in English would not be eligible and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Infants with bilateral clubfoot beginning Ponseti casting will have Mastisol applied to the skin prior to cast placement and will be followed through their casting course, typically 8–12 weeks. The study will record cast slippage, skin irritation or sores, development of complex clubfoot, length of treatment, recurrence, and any need for reconstructive surgery. Participants will receive standard Ponseti manipulations and casting with or without Mastisol and will be monitored clinically with follow-up extending up to five years. The goal is to determine whether improved cast adherence translates into faster or more durable correction and fewer complications.

Why it matters

Potential benefit: If successful, Mastisol could reduce cast slippage and skin complications, shorten Ponseti casting duration, and lower the chance of clubfoot recurrence or need for reconstruction.

How similar studies have gone: Clinicians commonly use skin adhesives to improve cast adherence and small reports suggest reduced slippage, but robust long-term trial data specifically in clubfoot are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with bilateral clubfeet
* Starting standard of care treatment with the Ponseti method between 0-12 weeks of age

  * For patients born pre-maturely their eligibility age will be based on a corrected gestational age
* Patients for whom at least one parent/guardian is able to converse, read, and write in English

Exclusion Criteria:

* Patients who do not have bilateral clubfoot
* Patients who are starting treatment for clubfoot after 12 weeks of age
* Patients whose parents/guardians are unable to converse, read, and write in English
* Patients whose parents/guardian do not provide or are not able to provide informed consent

Where it's running

  • UW-Health Pediatric Orthopedics Clinics
    Madison, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.